Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

Saturday, January 31, 2015

Indias Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine the US Federal Trade Commission said on Friday Sun Pharmaceutical said in April t...

Sanofi to set up insulin facility in Telangana, India

Friday, January 30, 2015

French vaccine manufacturer Sanofi though its Indian entity Shantha Biotechnics will set up an insulin production facility in Telangana involving an investment of Rs crore Sanofi proposes to manufacture Insuman one of its leading human insulin prod...

Venaxis receives FDA “Not Substantially Equivalent” Response on APPY1 510(k) Submission

Friday, January 30, 2015

Venaxis Inc an in vitro diagnostic company focused on advancing commercialization of its CE Marked APPY Test a rapid blood test for aiding in identifying children adolescent and young adult patients in the emergency room who are at low risk for appen...

Amerita, a Subsidiary of PharMerica, Accelerates Growth with the Acquisition of InfusionRx

Thursday, January 29, 2015

Amerita Inc a wholly owned subsidiary of PharMerica Corporation NYSEPMC today announced that it has completed the acquisition of Coastal Pharmaceutical Services Corporation dba InfusionRx InfusionRx Financial terms of the transaction were not disclos...

Adamis Pharmaceuticals receives Notice of Allowance for US and Japanese Patents for its Dry Powder Inhaler

Thursday, January 29, 2015

Adamis Pharmaceuticals Corporation recently received a notice of allowance that one of its patent applications for its proprietary dry powder inhaler Taper DPI will issue in the United States US Patent Application No and in Japan Japanese Patent App...

Ranbaxy forfeits 180 days exclusivity for generic Nexium

Wednesday, January 28, 2015

Ranbaxy Laboratories has lost the opportunity to exclusively market in the United States for six months the first generic version of Anglo Swedish drug innovator Astra Zenecas heartburn drug Nexium the Delhibased company said in a filing to the stock...

IntelliCell BioSciences Licenses Indication for Diabetes to Invigorcell

Wednesday, January 28, 2015

IntelliCell BioSciences Inc a regenerative medicine company utilizing adult autologous stromal vascular cells SVCs derived from the blood vessels found in adipose tissue today announced a license agreement for the indication of Diabetes Mellitus Inv...

Actavis to acquire UK generics firm Auden Mckenzie

Tuesday, January 27, 2015

Irelandheadquartered generic major Actavis NYSE ACT said today that it has reached agreement to acquire UKbased Auden Mckenzie a dynamic and fast growing company focused on the development licensing and marketing of niche generic medicines and propri...

Sanofi and Regeneron take the lead in bringing new cholesterol drug to US market

Tuesday, January 27, 2015

Regeneron REGNPharmaceuticals Inc and Sanofi may get a head start on their biggest competitor in bringing a new class of cholesterol drugs to the US market The US Food and Drug Administration has until July to make a decision on the companies appli...

Swiss drug company Novartis expects to gain momentum in business depaite weaker profit

Tuesday, January 27, 2015

Swiss pharmaceutical giantNovartisAG on Tuesday reported a fall in fourthquarter profit but said it expects its business to gain momentum this year despite uncertainty spawned by the strengthened Swiss franc Baselbased Novartis said net sales would...